| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. | President & Co-CEO, Director | Class A Common Stock | 21,269,420 | $188,021,673 | $8.84 | 03 Mar 2025 | By Family Trusts |
| Amneal Pharmaceuticals, Inc. | President & Co-CEO, Director | Performance-Based Restricted Stock Units | 890,410 | $7,871,224 | $8.84 | 03 Mar 2025 | Direct |
| Amneal Pharmaceuticals, Inc. | President & Co-CEO, Director | Class A Common Stock | 857,980 | $7,584,543 | $8.84 | 04 Mar 2025 | Direct |
| Amneal Pharmaceuticals, Inc. | President & Co-CEO, Director | Restricted Stock Units | 277,778 | $2,455,558 | $8.84 | 04 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2025 | 8 | -$2,867,328 | 4 | President & Co-CEO, Director | 05 Mar 2025, 19:33 |
| AMRX | Amneal Pharmaceuticals, Inc. | 04 Mar 2024 | 2 | $0 | 4 | President & Co-CEO, Director | 06 Mar 2024, 17:39 |
| AMRX | Amneal Pharmaceuticals, Inc. | 07 Nov 2023 | 2 | $0 | 4 | President & Co-CEO, Director | 08 Nov 2023, 18:20 |
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2023 | 1 | $0 | 4 | President & Co-CEO, Director, 10%+ Owner | 07 Mar 2023, 17:00 |
| AMRX | Amneal Pharmaceuticals, Inc. | 03 Mar 2022 | 1 | $0 | 4 | President & Co-CEO, Director, 10%+ Owner | 03 Mar 2022, 20:20 |
| AMRX | Amneal Pharmaceuticals, Inc. | 15 Dec 2021 | 2 | +$625,500 | 4 | President & Co-CEO, Director, 10%+ Owner | 17 Dec 2021, 15:15 |